GR antagonist, RU486, blocks DEX-induced up-regulation of CaD
expression. A549 cells were incubated with vehicle or 1 μm
DEX for the indicated times, and the expression levels of CaD mRNA (from real
time qPCR) (A) and CaD protein (from Western blot) (B) are
shown (mean ± S.D., **, p < 0.01,
***, p < 0.001; n.s., not significant).
C, A549 cells were pretreated with CHX for 2 h and incubated with
vehicle or 1 μm DEX for 24 h in the presence of CHX. CaD mRNA
was measured by real time qPCR. D and E, A549 cells
incubated with 1 μm DEX in the presence of 10 μm
RU486 or 10 μm RU28318. The expression of CaD mRNA (after 24 h
(D); from real time qPCR) and CaD protein (after 48 h (E);
from Western blot) are shown (mean ± S.D., ***, p
< 0.001). F, effect of RU486 or RU28318 on cell migration assayed
in Transwell migration chambers. A549 cells were incubated with a combination
of 1 μm DEX and 10 μm RU486 or RU28318 (mean
± S.D., ***, p < 0.001). G, A549 cells
were incubated with a combination of 1 μm DEX and 10
μm RU486 or 10 μm RU28318 for 48 h and stained
with anti-CaD antibody (green in merged image) and phalloidin
(red in merged image). Bar, 50 μm.